Rexall touts flu shots amid rising influenza activity
Rexall Pharma Plus is urging Ontario residents to get their flu shot and take other preventive measures amid reports of increased incidence of flu across the province.
CDR
CVS announces results of debt tender offers
CVS Caremark Corp. has bought back more than $1.7 billion in senior notes under a tender offer initiated late last month. Reporting the final results of the tender offer this week, CVS said an aggregate principal amount of $1.74 billion of the notes was tendered.
Dr. Pepper Snapple to launch five new TEN sodas
Next month, Dr Pepper Snapple Group plans to roll out 10-calorie versions of five of its most popular soda brands. The beverage company said Thursday that 7UP TEN, A&W TEN root beer, Sunkist TEN orange soda, Canada Dry TEN ginger ale and RC TEN Cola will be available in January at select
First-quarter earnings drop at Walgreens
Citing the impact of various items, including a reporting change for its partnership with Alliance Boots, Walgreen Co. saw net income sink for its fiscal 2013 first quarter, coming in well below Wall Street’s forecast. Walgreens said Friday that for the first quarter ended Nov. 30.
Miraculins’ PreVu test to go chainwide at London Drugs
Miraculins Inc.’s PreVu noninvasive skin cholesterol test is set to be rolled out to all London Drugs stores.
Walgreens work-site centers accredited as ‘medical homes’
Half of the primary care work-site health centers managed by Walgreens Employer Solutions Group have received Medical Home accreditation, Walgreen Co. and the Accreditation Association for Ambulatory Health Care (AAAHC) announced.
Rite Aid turns profit in third quarter
Rite Aid Corp. jumped a key financial hurdle by reporting net income for its fiscal 2013 third quarter, marking the company’s first quarterly profit in over five years. Rite Aid on Thursday posted net earnings of $61.9 million, or 7 cents per diluted share, for the 13-week third quarter ended Dec.
CutisPharma receives patent for suppository compounding
CutisPharma Inc. has been granted a patent regarding a method for the preparation, storage and dispensing of compounded suppositories. The company said Wednesday that the U.S.
Cast Comfort hits shelves at Shoppers Home Health
Bescot Healthcare Canada’s Cast Comfort, a spray that alleviates discomfort that may arise beneath a cast, is now being carried by Shoppers Home Health Care, a retail unit of Shoppers Drug Mart Corp.
Pharmacists seen as ‘sensible solution’ for health care delivery
A dearth of primary care doctors and high medical costs is shining a spotlight on pharmacists, among other providers, as a "sensible solution" for affordable health care delivery, according to a New York Times editorial. The National Association of Chain Drug Stores applauded the Dec.
GSK gets FDA OK for four-strain flu vaccine
GlaxoSmithKline has received Food and Drug Administration approval for Fluarix Quadrivalent, a four-strain seasonal flu vaccine. GSK said Monday that Fluarix Quadrivalent, for adults and children age 3 and older, represents the first intramuscular vaccine to cover against four influenza strains.
Tostitos expands tortilla chip, salsa lineup
Tostitos has unveiled Tostitos Catina tortilla chips and salsas, a new addition to its roster of snacks.
Ironwood, Forest ship IBS drug
Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc. have released Linzess, a medication for irritable bowel syndrome (IBS), to U.S. pharmacies.
Walgreens’ Crawford to join Allstate board
Kermit Crawford, president of pharmacy, health and wellness at Walgreen Co., has been elected to the board of directors at Allstate Corp. The insurance giant said Monday that Crawford will join its board effective Jan. 30, 2013, which will increase the company’s total number of board members to 13.
NACDS: Senator advocates for MTM coverage
The National Association of Chain Drug Stores is hailing Sen. Kay Hagan (D., N.C.) for her leadership on behalf of pharmacy patient care, in particular medication therapy management (MTM).
AstraZeneca: Crestor U.S. patent is upheld
AstraZeneca reported that the Court of Appeals for the Federal Circuit has upheld a decision of the U.S. District Court in Delaware that the substance patent protecting its cholesterol-lowering drug Crestor is "valid and enforceable.